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INTRODUCTION
 Sickle cell disease (SCD) is the most common 
hemoglobinopathy worldwide. It is prevalent 
in Africa, India, and Mediterranean countries, 
such as Greece, Turkey, and Italy. The disease is 
symptomatic only in homozygous individuals.1 
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ABSTRACT
Objective: In this study, we investigated the influence of electronic health records (EHR) and electronic 
vaccination schedule applications on the vaccination status of patients who were admitted to our Center 
for the treatment of sickle cell disease (SCD).
Methods: The vaccination status against influenza and pneumococcus infection was determined in 93 
patients who were  admitted to the hematology outpatient clinic, Baskent University Adana Hospital from 
April 2004 to March 2009. The vaccination status was then re-evaluated following establishment of EHR and 
electronic vaccination schedules in 2012.
Results: Of the 93 patients with SCD 21.5% (n=20) were vaccinated against pneumococcus and 21.5% (n=20) 
were regularly vaccinated against influenza. When the vaccination rates of 59 of 93 patients who presented 
for their regular control examinations were analyzed following establishment of EHR and vaccination 
schedules in 2012, these rates were 49.2% (n=29) and 50.8% (n=30) for influenza and pneumococcus, 
respectively, after EHR; there were 23.7% (n=14) and 20.3% (n=12), respectively, before EHR. A statistically 
significant difference was found between the vaccination rates before and after EHR (p < 0.05).
Conclusion: Although viral and bacterial infections are life-threatening health problems in patients with 
SCD, the vaccination rates were low in high-risk patients. However, these rates increased after application 
of electronic vaccination schedules.
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SCD causes chronic hemolysis, hemolytic crisis, 
and infections that may precipitate hemolysis.2
 Progressive vaso-occlusive damage to the spleen 
leads to a state of functional asplenia together 
with other immune system dysfunctions.3 People 
with SCD are at high risk for complications of 
influenza and pneumococcal infections because 
they are susceptible to bacterial infections caused 
by encapsulated organisms (including Streptococcus 
pneumoniae and Haemophilus influenzae) due to 
their impaired splenic function, increased airway 
hyperactivity, and risk of acute chest syndrome 
following respiratory infections.4 Vaccination 
against pneumococcus, influenza, and haemophilus 
influenzae Type-B (HiB) is recommended for 
patients with SCD.5-7 
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 Electronic health records (EHR) enable us to 
maintain records that cannot be created on paper. 
These include reminders for both patients and 
physicians about preventive health measures 
as well as ways to monitor the achievement of 
preventive healthcare goals, such as vaccination 
rates.8 Studies have shown improvements in 
preventive health services with the use of electronic 
reminder systems.9 In this study, we investigated 
the influence of EHR and electronic vaccination 
monitoring on vaccination rates against influenza 
and pneumococcus in patients with SCD.
METHODS
 Data from 93 patients who were admitted to the 
Hematology Department of Baskent University 
Adana Hospital from April 2004 to March 2009 
with a diagnosis of SCD and aged 16 to 58 years 
(64.6% female, 35.4% male) were included in this 
study. The sociodemographic data for the patients 
were obtained from the patients’ files. 
Sample Selection: The rates of vaccination against 
influenza and pneumococcus before 2012, when 
EHR were not being used, were compared with 
those after 2012. For this purpose, we re-analyzed 
the 2012 vaccination rates against influenza and 
pneumococcus for 93 patients (60 female, 33 male). 
However, 8 patients died and 26 did not present 
for their regular control examinations; these 
patients were excluded from the analysis. Thus, we 
evaluated the remaining 59 patients, and a second 
analysis was performed to compare the vaccination 
rates of these 59 patients before and after 2012. The 
only exclusion criterion was an age of <18 years. 
Data Collection: Electronic vaccination monitoring 
cards containing data on the date of vaccination 
were used to follow up with outpatients with SCD 
beginning in 2012. This record system was designed 
to notify the physicians.
Records and Data Security: The patients’ data were 
obtained from the Data Management System of the 
hospital (Nucleus version 9.3.39; Monad Software 
Company, Ankara, Turkey). Anemnesis forms 
and vaccination follow-up cards were created 
specifically for patients with SCD in this system to 
ensure inclusion of the vaccinations recommended 
by the World Health Organization (mainly influenza 
and pneumococcus). The vaccination status was 
evaluated when the patient was admitted to the 
outpatient clinic for any reason. Prior vaccinations 
were also recorded electronically. All patients who 
had not been previously vaccinated were given a 
copy of the vaccination card, which showed the 
scheduled dates of vaccinations. This software 
works in accordance with the relevant standard 
operating procedures for data authorization, 
backup, storage, and security, and the accuracy 
of the data is checked by the Data Audit Council 
assigned by the hospital management.10
Statistical Analyses: Data were analyzed using the 
SPSS 17.0 statistical package program (SPSS Inc., 
Chicago, IL, USA). Parametric data were compared 
using Student’s t test, and non-parametric data 
were compared using Pearson’s chi-square test 
and Fisher’s exact test. A p value of <0.05 was 
considered statistically significant.
Ethical Committee: Ethics Committee approval 
was obtained from Baskent University (KA17/45). 
RESULTS
 The initial audit and re-audit identified 93 patients 
(33 male, 60 female) with a mean age of 31.3 ± 9.7 
(range, 16-58) years and 59 patients (21 male, 38 
female) with a mean age of 29.0 ± 8.4 (range, 19-54) 
years. Among the 93 patients who were admitted 
to the outpatient clinic from 2004 to 2009, 21.5% (n 
= 20) were vaccinated against pneumococcus and 
21.5% (n = 20) were regularly vaccinated against 
influenza.
 According to the records of 59 patients who 
presented for their regular control examinations, 12 
(20.3%) had been vaccinated for pneumococcus and 
14 (23.7%) had been vaccinated for influenza before 
2012; these rates were 49.2% for influenza and 
50.8% for pneumococcus after 2012. A statistically 
significant difference was detected between these 
two time periods (p < 0.05).
DISCUSSION
 Because pneumococcal and influenza vaccines 
are the most frequently administered and updated, 
this study primarily focused on these two vaccines. 
The vaccines administered in accordance with the 
childhood vaccination schedule (HiB, hepatitis B 
virus, and meningococcus Group-C [Men-C] are 
often not recorded in adult vaccination records. 
Table-I: Comparison of vaccination rates before 
and after establishment of EHR.
Vaccine Vaccination Rate
 Before EHR After EHR P
 n % n %
Influenza 14 23.7 29 49.2 0.005
Pneumococcus 12 20.3 30 50.8 0.001
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 Given that patients with SCD are more susceptible 
to infection, particularly by S. pneumonia and 
HiB, due to splenic dysfunction, the inability to 
identify patients at high risk for these potentially 
fatal infections is a barrier to improvements in 
vaccination rates. Influenza, pneumococcus, 
and HiB vaccines have also been shown to be 
safe and effective in patients with SCD.7,11-13 
Pneumococcal immunization should begin with 
locally available pneumococcal conjugate vaccines 
(7, 10, or 13 valency) and supplemented at ages 2 
and 5-7 years with the 23-valent pneumococcal 
polysaccharide vaccine. HiB series, meningococcal 
conjugate vaccine, hepatitis B, and yearly influenza 
vaccinations are also recommended.5-7
 Infections in patients with SCD may lead to painful 
crises, hospitalization, and mortality. According to 
a study performed in the Eastern Mediterranean 
region by Karacaoglu et al., the most common causes 
of death were acute chest syndrome, followed by 
splenic sequestration and prolonged painful crisis-
related multi-organ failure.14 The researchers found 
that the mean age at death was 34.1 ± 10 (range, 18-
54) years for males, 40.1 ± 15 (range, 17-64) years for 
females, and 36.6 ± 13 (range, 17-64) years overall. 
Bundy et al.6 found that children with SCD were 
hospitalized due to influenza at a 56-fold higher 
rate than children without SCD. Pneumococcal 
bacteremia is particularly severe in young children. 
The risk persists in adults, especially for nosocomial 
infections.15 Seventy percent of cases of septicemia 
and meningitis among patients aged <5 years with 
SCD are caused by S. pneumonia.16
 Patients with SCD in the UK and USA are placed 
on prophylaxis and vaccinated against H. influenza 
and Pneumococcus sp.17,18 Twenty-five children aged 
≤16 years were analyzed in a study of 58 patients 
with SCD in the UK, and 14 (56%) were found to have 
completed immunization against pneumococcus, 
HiB, and MenC, with 8 (32%) having some coverage 
and 3 (12%) having none at all. Among 33 adults, 
only 4 patients (12%) had completed coverage, 
with up-to-date coverage against pneumococcus 
in 21%, HiB in 18%, and MenC in 15%. Current 
immunization against viral influenza was found in 
only 12% of adults and 8% of children, which are 
rates similar to those found in other UK studies.18 
The National Confidential Enquiry into Patient 
Outcome and Death (NCEPOD) study revealed 
6% influenza, 32% pneumococcal, 19% MenC, 
and 23% HiB vaccine uptake levels. 19,20 Similarly, 
an investigation of pneumococcal vaccine uptake 
in 3584 patients with either SCD or celiac disease 
revealed only 15.9% uptake in the five years 
preceding 2005.21 This study demonstrated a low 
level of vaccination uptake in patients with SCD 
in this region. Only 23.7% of patients had an up-
to-date influenza vaccine, and 20.3% had a current 
pneumococcal vaccine in the initial study.
 Many techniques have been used to improve the 
vaccination rates in patients with SCD throughout 
the world. A meta-analysis of improvement 
initiatives for community-dwelling adults showed 
success with the use of nonphysician personnel, 
activating patients through direct outreach, and 
audit and feedback aimed at physicians. Also 
successful were the use of a non-clinician patient 
navigator for direct outreach and providing 
updates to the clinical team on overall vaccination 
rates throughout the project.22 Although that study 
revealed the importance of measures aimed at 
improving vaccination rates, we could not make 
a comparison because EHR were not used in that 
study.  
 The Healthy People 2020 vaccination goals can 
be improved by EHR.23 The use of a database to 
target reminders to high-risk patients, followed by 
a recall letter for those remaining unvaccinated, 
was shown to increase influenza vaccination rates 
in a group of pediatric practices.24 Through the 
use of an alert, EHR resulted in an increase in 
influenza vaccination rates from 47% to 65% in 
a study of immunocompromised patients with 
rheumatologic diseases.25 Another study of 2-year-
old patients with SCD revealed that an EHR-based 
clinical alert intervention was associated with 
increases in captured opportunities for vaccination 
at both sick and well visits and detected significant 
improvements in immunization rates. As EHRs 
become more common in medical practice, such 
systems may transform immunization delivery 
to children.26 A study conducted by Asma27 with 
similar patient groups in the same region as our 
study revealed a pneumococcus immunization 
rate of 21.5% and an influenza immunization 
rate of 22.5% in adult patients with SCD before 
commencement of EHR for vaccination. We found 
these rates to be 50.8% and 49.2% for pneumococcus 
and influenza, respectively. Our study indicates 
that the Healthy People 2020 goal for influenza 
vaccination rates could be achieved for a medically 
and socially high-risk population through the 
use of enhanced EHR. Vaccination of adults with 
chronic diseases or hemoglobinopathy is important 
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and in accordance with the core competencies of 
family medicine, such as improvement of health 
and wellness through appropriate and effective 
interventions.28
Limitations of the study: First, the sample size was 
relatively small. Second, the study was conducted 
in one region, and the results cannot be assumed 
to represent all patients with SCD in Turkey. The 
potential causes of low vaccination rates may 
include insufficient knowledge among primary 
care physicians about this patient group; physicians 
may not volunteer for follow up of these patients 
and may refer them to tertiary care facilities where 
hematologists work. On the other hand, the high 
costs of tertiary care for chronic diseases may lead 
to low vaccination rates due to reduced tertiary 
care admissions. Consequently, these patients may 
be lost to follow up. Problems with transportation 
to specialized centers may be another factor that 
leads to low admissions and, thus, the inability to 
achieve sufficient vaccination rates. The media also 
influence people’s decisions, beliefs, and attitudes 
about vaccination.
CONCLUSIONS
 Viral and bacterial infections are an important 
cause of mortality and morbidity in patients with 
SCD. Studies of this patient group have shown 
insufficient vaccination rates. We believe that 
vaccination rates may improve through the use 
of vaccination cards, EHR, and regular follow up 
during vaccination periods.
Note: The work was performed at Adana Adult 
Bone Marrow Transplantation Unit.
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